Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Stopped losing weight on semaglutide after a year — worried about belly gain

A person who's been taking semaglutide for over a year shared that they lost more than 30 kg (about 66 pounds) but have hit a weight plateau for the last four months and even feel like their belly is a bit bigger. They're on a fairly high dose (they say 14 mg) and started the drug because of liver fibrosis and diabetes, both of which are now well controlled. They know they need medical follow-up but asked a community for clarity about why progress stopped. Semaglutide is the active drug in medicines like Ozempic and Wegovy. In plain terms, it acts like a natural gut hormone that helps reduce appetite and can slow how fast the stomach empties so you feel full longer. Doctors prescribe it for diabetes and, at different doses, for weight management. It's not a fat-melter on its own — it helps change eating behavior and blood sugar control, which over time leads to weight loss for many people. What the anecdote shows is a common pattern: people often see big losses early on, then the weight levels off. This post is a single-person report, not a formal study, so it can't prove cause and effect. Clinical trials of semaglutide show substantial average weight loss for many people, but results vary, and plateaus or small regain can happen. Also, doses, duration, other medications, changes in physical activity, aging, hormonal shifts, or even subtle increases in calories can affect progress. The poster notes good control of their diabetes and liver condition, which is important context but doesn't explain the recent stall by itself. Why this matters is practical: if you're using semaglutide and you stop losing weight, it doesn't necessarily mean the drug stopped working or that you've failed. It means it's time to reassess with a clinician. They can check for medical reasons (thyroid problems, new medications, water retention, hormonal changes), review diet and activity in detail, and consider whether dose, formulation, or adjunct strategies (behavioral support, exercise focus, or alternative therapies) should change. For someone with diabetes or liver disease, seeing these conditions improve is a win, but weight goals and health goals are related and both deserve follow-up. Caveats and risks: this is one person's report and not a medical verdict. Semaglutide can have side effects (nausea, GI upset, and in rare cases more serious issues) and stopping it often leads to weight regain unless other supports are in place. A "14 mg" dose is higher than some common dosing schedules mentioned publicly, so dose details should be confirmed with a prescriber — don’t change dosing on your own. If someone suspects new symptoms, weight distribution changes, or slowed progress, they should consult their doctor. Also, lifestyle factors and underlying conditions can change over time; only a clinician can sort those out. Bottom line: plateaus with semaglutide happen and aren’t uncommon — it’s sensible to get a medical check-up to look for causes and adjust the plan rather than assume the drug has simply stopped working.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE